Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Sucampo's cobiprostone granted fast track designation for oral mucositis

May 8, 2015

Oral Health Australia reports propeptides for periodontal diseases

Dec. 12, 2014

Liquidia forms oral health company Lq3 Pharmaceuticals

Sep. 16, 2014

C3 Jian completes phase II trial of C16G2

Sep. 10, 2014

C3 Jian begins phase II study of C-16G2 for prevention of dental caries

March 10, 2014

Soligenix begins phase II trial of SGX-942 for the treatment of oral mucositis

Dec. 12, 2013

Interleukin Genetics to launch PerioPredict periodontal disease test

Nov. 28, 2013

Clinical characterization of a novel pleiotropic anti-inflammatory effect of high-dose statin

Oct. 22, 2013

Acacia Pharma's phase II trial of APD-515 for xerostomia meets primary endpoint

Oct. 15, 2013

C3 Jian completes phase I trial of therapeutic for prevention of tooth decay

Aug. 23, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...